bromouracil has been researched along with Hymenolepiasis in 1 studies
Bromouracil: 5-Bromo-2,4(1H,3H)-pyrimidinedione. Brominated derivative of uracil that acts as an antimetabolite, substituting for thymine in DNA. It is used mainly as an experimental mutagen, but its deoxyriboside (BROMODEOXYURIDINE) is used to treat neoplasms.
5-bromouracil : A pyrimidine having keto groups at the 2- and 4-positions and a bromo group at the 5-position. Used mainly as an experimental mutagen.
Hymenolepiasis: Infection with tapeworms of the genus Hymenolepis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pappas, PW | 1 |
| Uglem, GL | 1 |
| Read, CP | 1 |
1 other study available for bromouracil and Hymenolepiasis
| Article | Year |
|---|---|
The influx of purines and pyrimidines across the brush border of Hymenolepis diminuta.
Topics: Absorption; Adenine; Animals; Binding Sites; Bromouracil; Carbon Isotopes; Cestoda; Culture Media; G | 1973 |